1 publication

  • Published Subscription

    Evolution of Cancer Biomarker and its Therapeutic Drug

    Abstract: The trend to develop personalized medicine in targeting the defective genes/proteins and its pathways have become a promising approach with a significant success rate seen so far. The causes of cancer vary from person to person. Mutation in a cancer-associated gene or causative gene such as EGFR, VEGF, mTOR etc will cause cancer and later metastasis but treatment has to be given by identifying the specific marker and targeting the …

    Published in Research and Reviews : A Journal of Life Sciences · Vol. 9, Issue 3, 2019 · pp. 15–27 Read article

Support